Viewing Study NCT00513695


Ignite Creation Date: 2025-12-24 @ 2:15 PM
Ignite Modification Date: 2026-02-21 @ 1:36 AM
Study NCT ID: NCT00513695
Status: COMPLETED
Last Update Posted: 2019-08-07
First Post: 2007-08-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer
Sponsor: University of Washington
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Inflammatory Breast Cancer View
None Male Breast Cancer View
None Stage II Breast Cancer View
None Stage IIIA Breast Cancer View
None Stage IIIB Breast Cancer View
None Stage IIIC Breast Cancer View
Keywords: